Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), L. Strizhakov (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation), L. Samokhodskaya (Moscow, Russian Federation), T. Krasnova (Moscow, Russian Federation). Genetic polymorphisms of inflammatory cytokines and endothelial dysfunction factors: role in patients with sarcoidosis. 1962

Member's Comments

No comment yet.

Related content which might interest you: Cytokines status, endothelial function in patients with pulmonary diseases Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005 Genetic polymorphisms of the renin-angiotensin system: role in patients with sarcoidosis Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Role of vascular endotelial growth factor polymorphisms in interstitial lung disease Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis Source: Eur Respir J 2009; 34: 1376-1382 Year: 2009 Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Correlation of IL-1 alpha and IL-4 promotor region gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006 The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 Effect of genetic polymorphisms of some cytokines and xenobiotic-metabolizing enzymes on the lung function in patients with COPD Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012 Frequency of TNFα and TNF receptor-1 polymorphisms in SSc patients with and without lung involvement Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001 Pro-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 148s Year: 2004 PAH and inflammation: its role in pathogenesis - is it of value to modulate it? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 The importance of inflammatory markers in sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 The role anti-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 122s Year: 2003 IL-13 polymorphism: predisposition towards COPD and asbestos-induced diseases Source: Eur Respir J 2001; 18: Suppl. 33, 535s Year: 2001 COPD: inflammatory mechanisms and systemic consequences Source: Eur Respir Mon 2013; 59: 13-27 Year: 2013 Investigation of angiogenetic markers (ENA-78 and GRO-α) in patients with pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 79s Year: 2005